Search
Showing results for "1"
Research
The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheezeA recently proposed method for classifying preschool wheeze is to describe it as either episodic (viral) wheeze or multiple trigger wheeze.
The Opportunity The Kids Research Institute Australia is looking for a motivated individual who would like to join the Information Communication and
News & Events
Free-living CGM Performance StudyParticipants are needed for a new study that will test the performance of a new Medtronic sensor with readings from finger-pricks.
Research
DeepEGFR a graph neural network for bioactivity classification of EGFR inhibitorsEpidermal Growth Factor Receptor (EGFR) plays a critical role in the development of several cancers. Thus, modulation/inhibition of EGFR activity is an appealing target of developing novel cancer therapeutics.
News & Events
Does your school pass the test?Do you feel your child is well supported by their school when it comes to managing diabetes? If so, our researchers want to hear from you.
News & Events
Frangipani Family DayFrangipani Family Day is an opportunity for CliniKids to celebrate the families we engage with through our clinical services and research.
News & Events
Seed Funding GrantsThe Rio Tinto Children's Diabetes Centre; a Breakthrough T1D Centre of Excellence is excited the announce the latest round of seed funding recipients.
News & Events
World Diabetes DayIt may only have been a matter of months since Abby Carlon was diagnosed with type 1 diabetes but already the 10-year-old knows more than most about the condition. That’s because she’s always kept an eye out for her little sister Mia who was diagnosed with type 1 diabetes when she was three.
Research
Genomic responses during acute human anaphylaxis are characterized by upregulation of innate inflammatory gene networksThe aim of this study was to examine the gene response of white blood cells in severe allergic reactions to identify genes that could be targets to new drugs...
